| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.98B | 139.71B | 138.23B | 143.93B | 131.08B | 118.25B |
| Gross Profit | 31.25B | 29.38B | 28.30B | 31.74B | 28.77B | 24.06B |
| EBITDA | 5.53B | 4.48B | 6.91B | 7.59B | 7.56B | 6.26B |
| Net Income | 2.02B | 1.15B | 2.78B | 3.24B | 3.29B | 2.36B |
Balance Sheet | ||||||
| Total Assets | 54.21B | 49.92B | 51.54B | 54.94B | 52.35B | 46.76B |
| Cash, Cash Equivalents and Short-Term Investments | 6.99B | 6.94B | 7.11B | 9.59B | 8.97B | 7.46B |
| Total Debt | 4.90B | 11.13B | 11.60B | 17.09B | 15.45B | 15.19B |
| Total Liabilities | 34.59B | 32.56B | 34.02B | 39.06B | 39.23B | 36.73B |
| Stockholders Equity | 19.65B | 17.39B | 17.51B | 14.64B | 11.40B | 8.24B |
Cash Flow | ||||||
| Free Cash Flow | 4.00B | 1.45B | 3.03B | 4.42B | 3.61B | 3.73B |
| Operating Cash Flow | 4.51B | 1.81B | 3.83B | 4.82B | 4.35B | 4.32B |
| Investing Cash Flow | -724.00M | -695.00M | -575.00M | -1.76B | -306.00M | -433.00M |
| Financing Cash Flow | -3.88B | -1.23B | -6.23B | -2.78B | -2.96B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥20.48B | 8.06 | ― | 3.09% | 4.92% | -27.88% | |
70 Outperform | ¥26.74B | 8.25 | ― | 3.86% | 1.18% | -5.05% | |
66 Neutral | ¥541.71B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
64 Neutral | ¥16.81B | 65.84 | ― | 3.66% | 8.62% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥60.21B | 12.19 | ― | 3.66% | 3.47% | -0.05% | |
42 Neutral | ¥74.62B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |